For the quarter ending 2026-03-31, BHC made $2,524M in revenue. -$1,423M in net income. Net profit margin of -56.38%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenues | 2,524 | 2,796 | 2,681 | 2,530 |
| Cost of goods sold (excluding amortization and impairments of intangible assets) and cost of other revenues-Product | 721 | 890* | 735 | 748 |
| Cost of goods sold (excluding amortization and impairments of intangible assets) and cost of other revenues-Product And Service Other | 17 | 18* | 15 | 16 |
| Selling, general and administrative | 861 | 882 | 795 | 894 |
| Research and development | 163 | 161 | 166 | 159 |
| Amortization of intangible assets | 241 | 236 | 253 | 256 |
| Goodwill impairments | 1,426 | 36* | - | - |
| Asset impairments | - | 7* | 1 | 0 |
| Restructuring, integration and separation costs | 13 | 28 | 17 | 31 |
| Other expense, net | -32 | -65 | -80 | 18 |
| Total expenses | 3,474 | 2,322 | 2,062 | 2,086 |
| Operating (loss) income | -950 | 474 | 619 | 444 |
| Interest income | 10 | 9 | 15 | 13 |
| Interest expense | 402 | 397 | 412 | 465 |
| Gain on extinguishment of debt | -1 | -19 | 3 | 178 |
| Foreign exchange and other | -11 | -11 | -7 | -30 |
| Loss before income taxes | -1,354 | 56 | 218 | 140 |
| Provision for income taxes | 77 | 159 | 37 | 12 |
| Net gain | -1,431 | -103 | 181 | 128 |
| Net gain attributable to noncontrolling interest | -8 | 9 | 2 | -20 |
| Net gain attributable to bausch health companies inc | -1,423 | -112 | 179 | 148 |
| Basic EPS | -3.82 | -0.301 | 0.48 | 0.4 |
| Diluted EPS | -3.82 | -0.293 | 0.48 | 0.4 |
| Basic Average Shares | 372,800,000 | 371,800,000 | 371,300,000 | 370,900,000 |
| Diluted Average Shares | 372,800,000 | 381,800,000 | 375,500,000 | 373,100,000 |
Bausch Health Companies Inc. (BHC)
Bausch Health Companies Inc. (BHC)